Where do we plan on going in the future? The hope is to provide sound scientific data which may contribute to policy decisions by regulators, and we also would like to identify new areas of regulatory research which might help policy development. We would also like to collaborate with scientists outside of FDA to identify new technologies which might be incorporated in the drug development process.
Thank you very much. I said it was short.
DR. KIBBE: Thank you. Wow.
There's got to be at least one question. Efraim, you're back. You can ask a question.
DR. SADEE: I have a quick question. Are the adverse effect or the side effect studies available on line? Do you make this information available or the data mining ‑‑
DR. SADRIEH: On the data mining, yes. We just started that. It depends on what we get and we have to look at that, but if it's data that's out in the public domain, it will definitely be published and it will be available to everybody. But it's an exciting project and we hope to get some good results from that one.